BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 11272901)

  • 41. Skin metastasis of dermatofibrosarcoma protuberans with distinct morphological features, confirmed by COL1A1-PDGFB fusion gene analysis.
    Kabumoto T; Fujiwara H; Kariya N; Tsujimoto T; Ito K; Ito M; Kobayashi H
    J Am Acad Dermatol; 2009 Jul; 61(1):130-2. PubMed ID: 19539850
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural and functional analysis of a chimeric protein COL1A1-PDGFB generated by the translocation t(17;22)(q22;q13.1) in Dermatofibrosarcoma protuberans (DP).
    Simon MP; Navarro M; Roux D; Pouysségur J
    Oncogene; 2001 May; 20(23):2965-75. PubMed ID: 11420709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concomitant DNA copy number amplification at 17q and 22q in dermatofibrosarcoma protuberans.
    Kiuru-Kuhlefelt S; El-Rifai W; Fanburg-Smith J; Kere J; Miettinen M; Knuutila S
    Cytogenet Cell Genet; 2001; 92(3-4):192-5. PubMed ID: 11435686
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determination of COL1A1-PDGFB breakpoints by next-generation sequencing in the molecular diagnosis of dermatofibrosarcoma protuberans.
    Zhu R; Yan J; Li B; Tan F; Yan W; Shen J; Fan L; Ding L; Chen Y; Tang Y; Liu Y; Bai Y
    Exp Mol Pathol; 2021 Oct; 122():104672. PubMed ID: 34371012
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biphasic dermatofibrosarcoma protuberans with a labyrinthine plexiform high-grade fibrosarcomatous transformation.
    Monteagudo C; Llombart B; Burgués O; Rubio L; Calabuig S; Sanmartín O; López-Guerrero JA
    J Cutan Pathol; 2015 Mar; 42(3):206-212. PubMed ID: 25410704
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Analysis of the COL1A1-PDGFB fusion gene in a case of dermatofibrosarcoma protuberans with a fibrosarcoma component].
    Llombart B; Sanmartín O; López-Guerrero JA; Monteagudo C; Calabuig S; Botella R; Nagore E; Requena C; Guillén C; Cremades A; Pellín A; Llombart-Bosch A
    Actas Dermosifiliogr; 2006 Jun; 97(5):337-41. PubMed ID: 16956568
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions.
    Dadone-Montaudié B; Alberti L; Duc A; Delespaul L; Lesluyes T; Pérot G; Lançon A; Paindavoine S; Di Mauro I; Blay JY; de la Fouchardière A; Chibon F; Karanian M; MacGrogan G; Kubiniek V; Keslair F; Cardot-Leccia N; Michot A; Perrin V; Zekri Y; Coindre JM; Tirode F; Pedeutour F; Ranchère-Vince D; Le Loarer F; Pissaloux D
    Mod Pathol; 2018 Nov; 31(11):1683-1693. PubMed ID: 29955147
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225.
    McArthur GA; Demetri GD; van Oosterom A; Heinrich MC; Debiec-Rychter M; Corless CL; Nikolova Z; Dimitrijevic S; Fletcher JA
    J Clin Oncol; 2005 Feb; 23(4):866-73. PubMed ID: 15681532
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A case of dermatofibrosarcoma protuberans of the vulva with a COL1A1/PDGFB fusion identical to a case of giant cell fibroblastoma.
    Vanni R; Faa G; Dettori T; Melis GB; Dumanski JP; O'Brien KP
    Virchows Arch; 2000 Jul; 437(1):95-100. PubMed ID: 10963386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - The impact of fibrosarcomatous transformation.
    Rutkowski P; Klimczak A; Ługowska I; Jagielska B; Wągrodzki M; Dębiec-Rychter M; Pieńkowska-Grela B; Świtaj T
    Eur J Surg Oncol; 2017 Jun; 43(6):1134-1141. PubMed ID: 28365129
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD34 positivity in fibrosarcomas which arise in dermatofibrosarcoma protuberans.
    Goldblum JR
    Arch Pathol Lab Med; 1995 Mar; 119(3):238-41. PubMed ID: 7534057
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular Characterization of Dermatofibrosarcoma Protuberans: The Clinicopathologic Significance of Uncommon Fusion Gene Rearrangements and Their Diagnostic Importance in the Exclusively Subcutaneous and Circumscribed Lesions.
    Lee PH; Huang SC; Wu PS; Tai HC; Lee CH; Lee JC; Kao YC; Tsai JW; Hsieh TH; Li CF; Li WS; Liu TT; Su YL; Yu SC; Huang HY
    Am J Surg Pathol; 2022 Jul; 46(7):942-955. PubMed ID: 35034038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complex t(5;8) involving the CSPG2 and PTK2B genes in a case of dermatofibrosarcoma protuberans without the COL1A1-PDGFB fusion.
    Bianchini L; Maire G; Guillot B; Joujoux JM; Follana P; Simon MP; Coindre JM; Pedeutour F
    Virchows Arch; 2008 Jun; 452(6):689-96. PubMed ID: 18253748
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.
    Mentzel T; Beham A; Katenkamp D; Dei Tos AP; Fletcher CD
    Am J Surg Pathol; 1998 May; 22(5):576-87. PubMed ID: 9591728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fibrosarcomatous variant of dermatofibrosarcoma protuberans showing COL1A1-PDGFB gene fusion, detected using a novel and disease-specific RT-PCR protocol.
    Mahajan H; Sharma R; Darmanian A; Peters GB
    Pathology; 2010; 42(5):488-91. PubMed ID: 20632833
    [No Abstract]   [Full Text] [Related]  

  • 56. Congenital atrophic dermatofibrosarcoma protuberans detected by COL1A1-PDGFB rearrangement.
    Makino M; Sasaoka S; Nakanishi G; Makino E; Fujimoto W
    Diagn Pathol; 2016 Mar; 11():24. PubMed ID: 26932148
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A case of dermatofibrosarcoma protuberans with a ring chromosome 5 and a rearranged chromosome 22 containing amplified COL1A1 and PDGFB sequences.
    Gisselsson D; Höglund M; O'Brien KP; Dumanski JP; Mertens F; Mandahl N
    Cancer Lett; 1998 Nov; 133(2):129-34. PubMed ID: 10072161
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary intrathoracic dermatofibrosarcoma protuberans.
    King L; López-Terrada D; Jakacky J; McCarville MB; Spunt SL; Bridge JA; Bahrami A
    Am J Surg Pathol; 2012 Dec; 36(12):1897-902. PubMed ID: 23108023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evolution of Dermatofibrosarcoma Protuberans to DFSP-Derived Fibrosarcoma: An Event Marked by Epithelial-Mesenchymal Transition-like Process and 22q Loss.
    Stacchiotti S; Astolfi A; Gronchi A; Fontana A; Pantaleo MA; Negri T; Brenca M; Tazzari M; Urbini M; Indio V; Colombo C; Radaelli S; Brich S; Dei Tos AP; Casali PG; Castelli C; Dagrada GP; Pilotti S; Maestro R
    Mol Cancer Res; 2016 Sep; 14(9):820-9. PubMed ID: 27256159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subcutaneous dermatofibrosarcoma protuberans, a rare subtype with predilection for the head: A retrospective series of 18 cases.
    Llombart B; Serra-Guillén C; Rubio L; Nagore E; Requena C; Traves V; Calomarde L; Bancalari B; López-Guerrero JA; Guillen-Barona C; Sanmartín O
    J Am Acad Dermatol; 2017 Sep; 77(3):503-511.e1. PubMed ID: 28420485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.